Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

AMLXAmylyx Pharmaceuticals, Inc.

Nasdaq · CIK 0001658551
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts254

Identity from submissions API

NameAmylyx Pharmaceuticals, Inc.
CIK0001658551
TickersAMLX
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN464600503
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone617-682-0917
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
55 CAMBRIDGE PARKWAY
SUITE 6W
CAMBRIDGE
MA
02142
MA
Mailing address
55 CAMBRIDGE PARKWAY
SUITE 6W
CAMBRIDGE
MA
02142
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

448 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001831942-26-000054 005-93265 261562969 34 15079
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-463803 005-93265 261562637 34 10767
2026-11-12 4 4 0001193125-26-458247 22209
2026-11-12 4 4 0001193125-26-458246 6915
2026-11-12 4 4 0001193125-26-458244 6894
2026-11-09 144 xsl144X01/primary_doc.xml 0001950047-26-010868 001-41199 261536569 33 5567
2026-11-09 144 xsl144X01/primary_doc.xml 0001950047-26-010867 001-41199 261536568 33 5679
2026-11-09 144 xsl144X01/primary_doc.xml 0001950047-26-010866 001-41199 261536563 33 5554
2026-11-05 10-Q 10-Q 0001193125-26-448529 001-41199 261524696 34 9119674 1 1
2026-11-05 8-K 8-K 2.02,9.01 0001193125-26-448525 001-41199 261524674 34 361562 1 1
2026-10-07 4 4 0001193125-26-416950 5107
2026-10-05 144 xsl144X01/primary_doc.xml 0001950047-26-010033 001-41199 261440917 33 5358
2026-09-14 4 4 0001193125-26-390510 7029
2026-09-14 4 4 0001193125-26-390509 11753
2026-09-14 4 4 0001193125-26-390508 6670
2026-09-14 4 4 0001193125-26-390506 7029
2026-09-14 4 4 0001193125-26-390507 7009
2026-09-11 144 xsl144X01/primary_doc.xml 0001193125-26-389247 001-41199 261374283 33 4620
2026-09-11 144 xsl144X01/primary_doc.xml 0001193125-26-389246 001-41199 261374285 33 4516
2026-09-11 144 xsl144X01/primary_doc.xml 0001193125-26-389245 001-41199 261374284 33 4572
2026-09-11 144 xsl144X01/primary_doc.xml 0001193125-26-389244 001-41199 261374281 33 5916
2026-09-11 144 xsl144X01/primary_doc.xml 0001193125-26-389243 001-41199 261374282 33 4599
2026-09-08 8-K 8-K 1.01 0001193125-26-385331 001-41199 261365712 34 147011 1 1
2026-09-02 4 4 0001193125-26-380152 10049
2026-08-20 4 4 0001193125-26-359679 10056
2026-08-20 4 4 0001193125-26-359678 4879
2026-08-20 4 4 0001193125-26-359677 4876
2026-08-20 4 4 0001193125-26-359676 4881
2026-08-20 4 4 0001193125-26-359675 4858
2026-08-20 8-K 8-K 1.01,9.01 0001193125-26-359418 001-41199 261301139 34 411670 1 1
2026-08-20 424B5 424B5 0001193125-26-359416 333-293956 261301137 33 892449 1 1
2026-08-18 424B5 424B5 0001193125-26-355696 333-293956 261291968 33 748832
2026-08-18 8-K 8-K 8.01,9.01 0001193125-26-354793 001-41199 261288577 34 7085531 1 1
2026-08-18 8-K 8-K 7.01,8.01,9.01 0001193125-26-354716 001-41199 261288433 34 180392 1 1
2026-08-06 10-Q 10-Q 0001193125-26-336682 001-41199 261245894 34 8126347 1 1
2026-08-06 8-K 8-K 2.02,9.01 0001193125-26-336670 001-41199 261245876 34 353229 1 1
2026-07-13 4 4 0001193125-26-301996 6912
2026-07-09 144 xsl144X01/primary_doc.xml 0001950047-26-006982 001-41199 261165963 33 5000
2026-06-08 4 4 0001193125-26-261647 5447
2026-06-08 4 4 0001193125-26-261641 5443
2026-06-08 4 4 0001193125-26-261640 5436
2026-06-08 4 4 0001193125-26-261638 5404
2026-06-08 4 4 0001193125-26-261637 5443
2026-06-04 8-K 8-K 5.07 0001193125-26-257390 001-41199 261064947 34 148085 1 1
2026-05-26 4 4 0001193125-26-239216 4503
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-226565 005-93265 26986551 34 10645
2026-05-07 10-Q 10-Q 0001193125-26-210292 001-41199 26950795 34 6955770 1 1
2026-05-07 8-K 8-K 2.02,9.01 0001193125-26-210286 001-41199 26950784 34 314378 1 1
2026-04-23 ARS ARS 0001193125-26-171809 001-41199 26885501 34 1055850
2026-04-23 DEFA14A DEFA14A 0001193125-26-171803 001-41199 26885493 34 849251
2026-04-23 DEF 14A DEF 14A 0001193125-26-171800 001-41199 26885485 34 4959318 1 1
2026-03-26 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-000598 005-93265 26797667 34 7185
2026-03-24 8-K 8-K 7.01,9.01 0001193125-26-120691 001-41199 26784154 34 21057700 1 1
2026-03-09 4 4 0001193125-26-098440 7209
2026-03-09 4 4 0001193125-26-098439 7226
2026-03-09 4 4 0001193125-26-098438 10744
2026-03-09 4 4 0001193125-26-098437 7230
2026-03-09 4 4 0001193125-26-098436 7231
2026-03-04 4 4 0001193125-26-091443 5233
2026-03-04 4 4 0001193125-26-091442 5211
2026-03-04 4 4 0001193125-26-091440 5234
2026-03-04 4 4 0001193125-26-091438 8689
2026-03-04 4 4 0001193125-26-091436 5229
2026-03-03 S-8 S-8 0001193125-26-088117 333-293967 26713843 33 171332 1 1
2026-03-03 S-3ASR S-3ASR 0001193125-26-086735 333-293956 26711096 33 1092152 1 1
2026-03-03 10-K 10-K 0001193125-26-086645 001-41199 26711024 34 13377026 1 1
2026-03-03 8-K 8-K 2.02,9.01 0001193125-26-086629 001-41199 26711001 34 399769 1 1
2026-03-02 144 xsl144X01/primary_doc.xml 0001898314-26-000002 001-41199 26708172 33 7286
2026-03-02 144 xsl144X01/primary_doc.xml 0001326969-26-000002 001-41199 26708173 33 5225
2026-03-02 144 xsl144X01/primary_doc.xml 0001235598-26-000002 001-41199 26708174 33 5835
2026-03-02 144 xsl144X01/primary_doc.xml 0001913765-26-000002 001-41199 26708170 33 5891
2026-03-02 144 xsl144X01/primary_doc.xml 0001898644-26-000002 001-41199 26708169 33 7265
2026-02-25 4 4 0001193125-26-071460 5187
2026-02-23 144 xsl144X01/primary_doc.xml 0001193125-26-064078 001-41199 26665604 33 5219
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-26-054741 005-93265 26641840 34 13376
2026-02-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-26-000907 005-93265 26623693 34 12517
2026-02-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-26-000374 005-93265 26601816 34 11612
2026-02-04 4 4 0001193125-26-037553 8689
2026-02-04 4 4 0001193125-26-037552 5154
2026-02-04 4 4 0001193125-26-037548 5171
2026-02-04 4 4 0001193125-26-037544 5174
2026-02-02 144 xsl144X01/primary_doc.xml 0001193125-26-033641 001-41199 26587932 33 6593
2026-02-02 144 xsl144X01/primary_doc.xml 0001193125-26-033640 001-41199 26587930 33 6614
2026-02-02 144 xsl144X01/primary_doc.xml 0001193125-26-033639 001-41199 26587931 33 4546
2026-02-02 144 xsl144X01/primary_doc.xml 0001193125-26-033638 001-41199 26587928 33 5164
2026-01-30 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000102909-26-000077 005-93265 26581890 34 6935
2026-01-21 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-26-000638 005-93265 26545843 34 10918
2026-01-20 4 4 0001193125-26-017057 13745
2026-01-20 4 4 0001193125-26-017056 13774
2026-01-16 144 xsl144X01/primary_doc.xml 0001950047-26-000500 001-41199 26539463 33 6442
2026-01-16 144 xsl144X01/primary_doc.xml 0001950047-26-000499 001-41199 26539426 33 6458
2026-01-15 144 xsl144X01/primary_doc.xml 0001950047-26-000451 001-41199 26536472 33 5745
2026-01-15 144 xsl144X01/primary_doc.xml 0001950047-26-000449 001-41199 26536419 33 5736
2026-01-14 4 4 0001193125-26-012921 4486
2026-01-08 4 4 0001193125-26-007669 8880
2026-01-08 4 4 0001193125-26-007666 5151
2026-01-08 4 4 0001193125-26-007664 5172
2026-01-08 8-K 8-K 7.01,8.01,9.01 0001193125-26-006991 001-41199 26517332 34 20467149 1 1
2026-01-06 144 xsl144X01/primary_doc.xml 0001193125-26-004407 001-41199 26511419 33 4380
2026-01-06 144 xsl144X01/primary_doc.xml 0001193125-26-004404 001-41199 26511392 33 4485
2026-01-06 144 xsl144X01/primary_doc.xml 0001193125-26-004394 001-41199 26511381 33 4464
2025-12-23 4 4 0001193125-25-331289 4366
2025-12-03 4 4 0001193125-25-306818 5118
2025-12-01 144 xsl144X01/primary_doc.xml 0001193125-25-303857 001-41199 251539619 33 4925
2025-11-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001831942-25-000033 005-93265 251492232 34 14805
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-005011 005-93265 251486174 34 12087
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-25-282838 005-93265 251485398 34 10494
2025-11-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-004887 005-93265 251475745 34 12472
2025-11-06 10-Q 10-Q 0001193125-25-268059 001-41199 251456120 34 8744186 1 1
2025-11-06 8-K 8-K 2.02,9.01 0001193125-25-268043 001-41199 251456083 34 384410 1 1
2025-10-30 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000102909-25-000074 005-93265 251434365 34 6196
2025-10-07 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-002303 005-93265 251379719 34 11451
2025-10-02 4 4 0001193125-25-228343 6917
2025-10-02 4 4 0001193125-25-228342 5115
2025-10-02 4 4 0001193125-25-228341 7431
2025-10-02 4 4 0001193125-25-228340 6897
2025-10-02 4 4 0001193125-25-228339 5119
2025-09-10 8-K 8-K 1.01,9.01 0001193125-25-200159 001-41199 251306441 34 393265 1 1
2025-09-10 424B5 424B5 0001193125-25-200144 333-285525 251306365 33 772558
2025-09-09 424B5 424B5 0001193125-25-199270 333-285525 251304114 33 772114
2025-08-27 8-K 8-K 8.01 0001193125-25-189109 001-41199 251259689 34 131830 1 1
2025-08-14 4 4 0000950170-25-108912 6711
2025-08-12 144 xsl144X01/primary_doc.xml 0001950047-25-005671 001-41199 251207122 33 4896
2025-08-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-003514 005-93265 251204589 34 12328
2025-08-07 10-Q 10-Q 0001193125-25-174948 001-41199 251191571 34 8294837 1 1
2025-08-07 8-K 8-K 2.02,9.01 0000950170-25-104546 001-41199 251191519 34 377042 1 1
2025-07-29 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000932471-25-000763 005-93265 251159031 34 6090
2025-07-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-002997 005-93265 251132151 34 10710
2025-06-25 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-002784 005-93265 251074570 34 17855
2025-06-09 4 4 0000950170-25-083734 5248
2025-06-09 4 4 0000950170-25-083719 5248
2025-06-09 4 4 0000950170-25-083717 5241
2025-06-09 4 4 0000950170-25-083713 5110
2025-06-09 4 4 0000950170-25-083709 5242
2025-06-05 8-K 8-K 5.07 0001193125-25-135860 001-41199 251027055 34 143472 1 1
2025-05-27 4 4 0000950170-25-077677 4572
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-072740 005-93265 25954095 34 10375
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-002375 005-93265 25952147 34 12104
2025-05-12 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-002243 005-93265 25932863 34 15786
2025-05-08 10-Q 10-Q 0000950170-25-066363 001-41199 25923809 34 7356561 1 1
2025-05-08 8-K 8-K 2.02,9.01 0000950170-25-066355 001-41199 25923780 34 332354 1 1
2025-04-24 ARS ARS 0000950170-25-057669 001-41199 25863567 34 6183911
2025-04-24 DEFA14A DEFA14A 0000950170-25-057667 001-41199 25863562 34 856672
2025-04-24 DEF 14A DEF 14A 0000950170-25-057665 001-41199 25863551 34 5466367 1 1
2025-04-02 4 4 0000950170-25-049581 7426
2025-04-02 4 4 0000950170-25-049567 5115
2025-04-02 4 4 0000950170-25-049560 5109
2025-04-02 4 4 0000950170-25-049513 5093
2025-04-02 4 4 0000950170-25-049495 5113
2025-03-26 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000794 333-285525 25774978 33 1719
2025-03-24 CORRESP filename1.htm 0001193125-25-061425 6956
2025-03-24 4 4 0000950170-25-043849 4696
2025-03-10 4 4 0000950170-25-036717 7172
2025-03-10 4 4 0000950170-25-036712 7180
2025-03-10 4 4 0000950170-25-036711 7179
2025-03-10 4 4 0000950170-25-036708 7158
2025-03-10 4 4 0000950170-25-036707 9491
2025-03-05 UPLOAD filename1.pdf 0000000000-25-002463 333-285525 40249
2025-03-05 4 4 0000950170-25-033725 5118
2025-03-05 4 4 0000950170-25-033719 5099
2025-03-05 4 4 0000950170-25-033717 5117
2025-03-04 S-8 S-8 0001193125-25-045578 333-285534 25704259 33 61991
2025-03-04 S-3 S-3 0001193125-25-044854 333-285525 25701559 33 960644
2025-03-04 10-K 10-K 0000950170-25-031309 001-41199 25701355 34 14569854 1 1
2025-03-04 POSASR POSASR 0001193125-25-044765 333-270505 25701320 33 351292
2025-03-04 8-K 8-K 2.02,9.01 0000950170-25-031303 001-41199 25701298 34 411639 1 1
2025-02-26 4 4 0000950170-25-027833 5115
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-021288 005-93265 25629584 34 12922
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-021226 005-93265 25628915 34 10547
2025-02-06 4 4 0000950170-25-015701 6555
2025-02-05 4 4 0000950170-25-014620 5116
2025-02-05 4 4 0000950170-25-014610 5099
2025-02-05 4 4 0000950170-25-014607 5120
2025-01-28 4 4 0000950170-25-009913 4618
2025-01-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-000221 005-93265 25529985 34 18653
2025-01-10 8-K 8-K 1.01,9.01 0001193125-25-004547 001-41199 25523997 34 367263 1 1
2025-01-10 424B5 424B5 FINAL 0001193125-25-004537 333-270505 25523895 33 701505
2025-01-10 424B5 424B5 0001193125-25-004002 333-270505 25520094 33 669264
2025-01-08 4 4 0000950170-25-003533 5119
2025-01-08 4 4 0000950170-25-003531 5098
2024-12-30 8-K 8-K 7.01 0001193125-24-286212 001-41199 241586962 34 145541 1 1
2024-12-03 4 4 0000950170-24-132885 5123
2024-11-12 SC 13G/A UnitedStates_13G__AmylyxPhar.txt 0000932471-24-000840 005-93265 241446459 34 6504
2024-11-07 10-Q 10-Q 0000950170-24-122833 001-41199 241433340 34 8113349 1 1
2024-11-07 8-K 8-K 2.02,9.01 0000950170-24-122779 001-41199 241433112 34 376052 1 1
2024-11-06 4 4 0000950170-24-122640 6560
2024-11-04 SC 13G UnitedStates_13G__AmylyxPhar.txt 0000932471-24-000246 005-93265 241421358 34 5566
2024-10-25 SC 13G SC 13G 0001193125-24-244246 005-93265 241397986 34 65569
2024-10-17 8-K 8-K 8.01 0001193125-24-238572 001-41199 241376100 34 165344 1 1
2024-10-02 4 4 0000950170-24-111812 5123
2024-10-02 4 4 0000950170-24-111811 5100
2024-10-02 4 4 0000950170-24-111809 5124
2024-10-02 4 4 0000950170-24-111805 5118
2024-09-25 4 4 0000950170-24-109397 6535
2024-09-16 4 4 0000950170-24-106915 6541
2024-09-16 4 4 0000950170-24-106910 7095
2024-09-09 4 4 0000950170-24-104737 4710
2024-09-05 4/A 4/A 0000950170-24-104191 8457
2024-09-05 4 4 0000950170-24-104186 4575
2024-08-26 SC 13G SC 13G 0001193125-24-207220 005-93265 241242807 34 77330
2024-08-08 10-Q 10-Q 0000950170-24-093311 001-41199 241186020 34 7575987 1 1
2024-08-08 8-K 8-K 2.02,9.01 0000950170-24-093304 001-41199 241185999 34 367700 1 1
2024-07-10 8-K 8-K 2.01 0001193125-24-177000 001-41199 241108672 34 143907 1 1
2024-07-08 SC 13G/A us03237h1014_070824.txt 0001086364-24-008253 005-93265 241105245 34 12898
2024-06-21 8-K 8-K 1.01,9.01 0000950170-24-076339 001-41199 241061326 34 932001 1 1
2024-06-07 4 4 0000950170-24-070811 5258
2024-06-07 4 4 0000950170-24-070804 5258
2024-06-07 4 4 0000950170-24-070797 5249
2024-06-07 4 4 0000950170-24-070778 5120
2024-06-07 4 4 0000950170-24-070769 5251
2024-06-06 8-K 8-K 5.07 0001193125-24-156050 001-41199 241025068 34 153742 1 1
2024-05-16 4 4 0000950170-24-061294 5675
2024-05-16 4 4 0000950170-24-061293 4966
2024-05-15 144 xsl144X01/primary_doc.xml 0001950047-24-003736 001-41199 24951537 33 4901
2024-05-09 10-Q 10-Q 0000950170-24-056269 001-41199 24928537 34 6962010 1 1
2024-05-09 8-K 8-K 2.02,9.01 0000950170-24-056254 001-41199 24928503 34 321564 1 1
2024-04-24 ARS ARS 0000950170-24-047247 001-41199 24866715 34 6513982
2024-04-24 DEFA14A DEFA14A 0000950170-24-047244 001-41199 24866708 34 896812
2024-04-24 DEF 14A DEF 14A 0000950170-24-047243 001-41199 24866706 34 5377099 1 1
2024-04-18 4 4 0000950170-24-045698 9505
2024-04-18 4 4 0000950170-24-045696 7172
2024-04-18 4 4 0000950170-24-045695 7189
2024-04-18 4 4 0000950170-24-045694 7193
2024-04-18 4 4 0000950170-24-045693 7194
2024-04-10 8-K 8-K 8.01 0001193125-24-091463 001-41199 24834369 34 151441 1 1
2024-04-04 8-K 8-K 2.05,7.01,8.01,9.01 0001193125-24-086609 001-41199 24821609 34 183156 1 1
2024-03-15 4 4 0000950170-24-032246 5356
2024-03-15 3 3 0000950170-24-032235 11976
2024-03-14 8-K 8-K 5.02 0001193125-24-067471 001-41199 24748118 34 145138 1 1
2024-03-11 SC 13G SC 13G 0001193125-24-064391 005-93265 24736678 34 96131
2024-03-08 8-K 8-K 7.01,8.01,9.01 0001193125-24-062878 001-41199 24732322 34 194128 1 1
2024-03-07 4 4 0000950170-24-027923 5101
2024-03-07 4 4 0000950170-24-027922 5122
2024-03-07 4 4 0000950170-24-027918 7853
2024-03-07 4 4 0000950170-24-027921 5118
2024-02-28 4 4 0000950170-24-022434 8399
2024-02-28 4 4 0000950170-24-022413 7278
2024-02-28 4 4 0000950170-24-022410 7299
2024-02-28 4 4 0000950170-24-022400 7291
2024-02-27 4 4 0000950170-24-021472 5076
2024-02-22 S-8 S-8 0001193125-24-042863 333-277274 24665286 33 66725
2024-02-22 10-K 10-K 0000950170-24-018447 001-41199 24662398 34 17518886 1 1
2024-02-22 8-K 8-K 2.02,9.01 0000950170-24-018409 001-41199 24662269 34 358969 1 1
2024-02-14 SC 13G/A SC 13G/A 0001193125-24-036371 005-93265 24639368 34 64741
2024-02-14 SC 13G/A sayw24021408_13ga.htm 0000905148-24-000624 005-93265 24633677 34 308919
2024-02-14 SC 13G/A AMYLYX PHARMACEUTICALS, INC. 0000902664-24-001552 005-93265 24632249 34 77992
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-020282 005-93265 24627373 34 13021
2024-01-29 SC 13G us03237h1014_012924.txt 0001086364-24-005648 005-93265 24574970 34 13563
2024-01-29 4 4 0000950170-24-008347 4177
2024-01-18 4 4 0000950170-24-005437 4178
2024-01-11 4 4 0000950170-24-003985 5122
2024-01-11 4 4 0000950170-24-003984 6226
2024-01-11 4 4 0000950170-24-003981 5242
2024-01-11 4 4 0000950170-24-003974 5087
2023-12-29 4 4 0000950170-23-073837 6587
2023-12-20 UPLOAD filename1.pdf 0000000000-23-013886 39667
2023-12-19 4 4 0000950170-23-071533 4315
2023-12-19 CORRESP filename1.htm 0001193125-23-298299 38292
2023-12-11 SC 13G AMYLYX PHARMACEUTICALS, INC. 0000902664-23-005832 005-93265 231478286 34 84765
2023-12-07 8-K 8-K 7.01 0001193125-23-290302 001-41199 231471052 34 142611 1 1
2023-12-05 UPLOAD filename1.pdf 0000000000-23-013232 44364
2023-11-29 4 4 0000950170-23-066796 7124
2023-11-29 3 3 0000950170-23-066787 11729
2023-11-20 4 4 0000950170-23-065259 18365
2023-11-09 10-Q 10-Q 0000950170-23-061516 001-41199 231390018 34 11003451 1 1
2023-11-09 8-K 8-K 2.02,9.01 0000950170-23-061505 001-41199 231389966 34 413261 1 1
2023-11-02 4 4 0000950170-23-058113 5892
2023-10-13 8-K 8-K 8.01 0001193125-23-256178 001-41199 231325743 34 143061 1 1
2023-10-04 SC 13D/A SC 13D/A 0001193125-23-250741 005-93265 231308169 34 633589
2023-08-24 4 4 0000950170-23-044381 7714
2023-08-17 4 FORM 4 SUBMISSION 0000899243-23-018211 5476
2023-08-17 SC 13D/A SC 13D/A 0001193125-23-215139 005-93265 231182895 34 171062
2023-08-17 4 4 0000950170-23-043242 4881
2023-08-15 144 xsl144X01/primary_doc.xml 0001950047-23-003083 001-41199 231174962 33 4657
2023-08-10 S-8 S-8 0001193125-23-209106 333-273883 231160205 33 196231
2023-08-10 10-Q 10-Q 0000950170-23-041335 001-41199 231159556 34 12180305 1 1
2023-08-10 8-K 8-K 2.02,9.01 0000950170-23-041274 001-41199 231159118 34 458230 1 1
2023-07-26 8-K 8-K 8.01,9.01 0001193125-23-194655 001-41199 231114090 34 8832513 1 1
2023-07-14 4 4 0000950170-23-033003 6664
2023-06-23 8-K 8-K 8.01,9.01 0001193125-23-173965 001-41199 231038695 34 171965 1 1
2023-06-12 4 FORM 4 SUBMISSION 0000899243-23-015412 5402
2023-06-12 4 FORM 4 SUBMISSION 0000899243-23-015410 9326
2023-06-12 4 FORM 4 SUBMISSION 0000899243-23-015408 9474
2023-06-12 4 FORM 4 SUBMISSION 0000899243-23-015406 9466
2023-06-09 SC 13G AMYLYX.txt 0000769993-23-000334 005-93265 231005086 34 22776
2023-06-09 8-K 8-K 5.07 0001193125-23-164027 001-41199 231003923 34 153937 1 1
2023-05-24 4 4 0000950170-23-023942 4301
2023-05-19 4 4 0000950170-23-023240 4294
2023-05-18 4 FORM 4 SUBMISSION 0000899243-23-013289 12162
2023-05-17 4 4 0000950170-23-022775 12338
2023-05-16 144 xsl144X01/primary_doc.xml 0001950047-23-000660 001-41199 23928068 33 5325
2023-05-15 144 xsl144X01/primary_doc.xml 0001950047-23-000613 001-41199 23923061 33 6773
2023-05-11 10-Q 10-Q 0000950170-23-021369 001-41199 23912074 34 10235023 1 1
2023-05-11 8-K 8-K 2.02,9.01 0000950170-23-021181 001-41199 23910750 34 402530 1 1
2023-04-27 ARS ARS 0000950170-23-015288 001-41199 23857208 34 6678202
2023-04-27 DEFA14A DEFA14A 0000950170-23-015281 001-41199 23857036 34 1151998
2023-04-27 DEF 14A DEF 14A 0000950170-23-015261 001-41199 23856810 34 2475563
2023-04-26 4/A FORM 4/A SUBMISSION 0000899243-23-011781 8817
2023-04-26 3/A FORM 3/A SUBMISSION 0000899243-23-011780 5450
2023-04-19 4 FORM 4 SUBMISSION 0000899243-23-011461 14767
2023-04-17 144 xsl144X01/primary_doc.xml 0001950047-23-000138 001-41199 23824101 33 6061
2023-04-03 SC 13D/A SC 13D/A 0001193125-23-089658 005-93265 23793388 34 203473
2023-03-31 4 FORM 4 SUBMISSION 0000899243-23-010078 5544
2023-03-29 4 FORM 4 SUBMISSION 0000899243-23-009972 9616
2023-03-24 4/A FORM 4/A SUBMISSION 0000899243-23-009602 20649
2023-03-24 4/A FORM 4/A SUBMISSION 0000899243-23-009600 28806
2023-03-23 4 FORM 4 SUBMISSION 0000899243-23-009506 7586
2023-03-21 8-K 8-K 5.02,9.01 0001193125-23-075821 001-41199 23750252 34 171354 1 1
2023-03-20 4 FORM 4 SUBMISSION 0000899243-23-009182 11593
2023-03-20 4 FORM 4 SUBMISSION 0000899243-23-009180 7602
2023-03-20 4 FORM 4 SUBMISSION 0000899243-23-009179 6820
2023-03-20 4 FORM 4 SUBMISSION 0000899243-23-009178 11551
2023-03-20 4 FORM 4 SUBMISSION 0000899243-23-009177 7596
2023-03-20 4 FORM 4 SUBMISSION 0000899243-23-009172 7433
2023-03-20 4 FORM 4 SUBMISSION 0000899243-23-009171 11572
2023-03-20 4 FORM 4 SUBMISSION 0000899243-23-009168 11530
2023-03-20 3 FORM 3 SUBMISSION 0000899243-23-009164 6895
2023-03-17 4 FORM 4 SUBMISSION 0000899243-23-008858 5538
2023-03-16 144 xsl144X01/primary_doc.xml 0001950047-23-000040 001-41199 23739880 33 5909
2023-03-16 144 xsl144X01/primary_doc.xml 0001950047-23-000036 001-41199 23739544 33 5313
2023-03-16 144 xsl144X01/primary_doc.xml 0001950047-23-000035 001-41199 23739530 33 4530
2023-03-16 144 xsl144X01/primary_doc.xml 0001950047-23-000032 001-41199 23739475 33 5349
2023-03-16 144 xsl144X01/primary_doc.xml 0001950047-23-000031 001-41199 23739460 33 5350
2023-03-16 4 FORM 4 SUBMISSION 0000899243-23-008733 15796
2023-03-13 S-8 S-8 0001193125-23-069220 333-270509 23728318 33 65526
2023-03-13 S-3ASR S-3ASR 0001193125-23-069187 333-270505 23728208 33 915902
2023-03-13 10-K 10-K 0000950170-23-007609 001-41199 23727982 34 25836347 1 1
2023-03-13 8-K 8-K 2.02,9.01 0000950170-23-007580 001-41199 23727588 34 479017 1 1
2023-03-06 4 FORM 4 SUBMISSION 0000899243-23-007120 5539
2023-02-28 4 FORM 4 SUBMISSION 0000899243-23-006418 5183
2023-02-28 4 FORM 4 SUBMISSION 0000899243-23-006394 7573
2023-02-24 4 FORM 4 SUBMISSION 0000899243-23-006123 11643
2023-02-14 5 FORM 5 SUBMISSION 0000899243-23-004990 15075
2023-02-14 SC 13G/A SC 13G/A 0001193125-23-038739 005-93265 23627270 34 64331
2023-02-14 SC 13G/A SC 13G/A 0001140361-23-006816 005-93265 23626290 34 307117
2023-02-14 8-K 8-K 7.01 0001193125-23-036988 001-41199 23622058 34 150842 1 1
2023-02-13 SC 13G us03237h1014_021323.txt 0001306550-23-008648 005-93265 23617097 34 13105
2023-02-09 SC 13G SCHEDULE 13G 0001104659-23-015304 005-93265 23602439 34 12910
2023-01-11 5 FORM 5 SUBMISSION 0000899243-23-001580 9441
2023-01-10 4 FORM 4 SUBMISSION 0000899243-23-001526 7066
2023-01-10 4 FORM 4 SUBMISSION 0000899243-23-001524 7083
2023-01-10 4 FORM 4 SUBMISSION 0000899243-23-001523 7047
2023-01-10 4 FORM 4 SUBMISSION 0000899243-23-001520 7103
2023-01-10 4 FORM 4 SUBMISSION 0000899243-23-001517 7104
2023-01-04 4 FORM 4 SUBMISSION 0000899243-23-000755 6864
2022-12-06 8-K 8-K 1.01,9.01 0001193125-22-299375 001-41199 221447692 34 163636 1 1
2022-11-10 10-Q 10-Q 0000950170-22-024465 001-41199 221377296 34 11734588 1 1
2022-11-10 8-K 8-K 2.02,9.01 0000950170-22-024448 001-41199 221377085 34 482803 1 1
2022-11-02 8-K 8-K 5.02 0001193125-22-275812 001-41199 221353903 34 147700 1 1
2022-10-07 424B4 424B4 0001193125-22-259634 333-267730 221301066 33 3446764
2022-10-06 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2022-10-06 16:00:00 9999999995-22-002975 333-267730 221299207 33 1678
2022-10-06 S-1MEF S-1MEF 0001193125-22-259069 333-267766 221299173 33 67900
2022-10-04 CORRESP filename1.htm 0001193125-22-257686 13303
2022-10-04 CORRESP filename1.htm 0001193125-22-257677 7905
2022-10-04 S-1 S-1 0001193125-22-257577 333-267730 221291426 33 3753530
2022-09-30 SC 13D/A SC 13D/A 0001193125-22-255483 005-93265 221284070 34 187579
2022-09-30 8-K 8-K 8.01,9.01 0001193125-22-254838 001-41199 221282322 34 195256 1 1
2022-09-21 SC 13G AMLX_SC13G.htm 0001273087-22-000108 005-93265 221256632 34 81966
2022-09-12 SC 13G/A SC 13G/A 0001140361-22-032972 005-93265 221237261 34 301021
2022-09-09 4 FORM 4 0001140361-22-032970 46326
2022-08-31 UPLOAD filename1.pdf 0000000000-22-009441 40549
2022-08-24 DRS filename1.htm 0000950123-22-009682 377-06329 221192166 33 3487945
2022-08-11 8-K 8-K 2.02,9.01 0001193125-22-218745 001-41199 221157058 34 217845 1 1
2022-08-11 10-Q 10-Q 0000950170-22-016883 001-41199 221156109 34 10313984 1 1
2022-08-11 8-K 8-K 2.02,9.01 0000950170-22-016880 001-41199 221156017 34 409840 1 1
2022-07-08 4 FORM 4 SUBMISSION 0000899243-22-025847 10944
2022-07-05 8-K 8-K 8.01,9.01 0001193125-22-188015 001-41199 221066389 34 163055 1 1
2022-06-21 SC 13G SC 13G 0001193125-22-177148 005-93265 221026306 34 63568
2022-06-13 8-K 8-K 8.01,9.01 0001193125-22-172425 001-41199 221010691 34 178973 1 1
2022-06-10 4 FORM 4 SUBMISSION 0000899243-22-021890 5368
2022-06-10 4 FORM 4 SUBMISSION 0000899243-22-021889 5230
2022-06-10 4 FORM 4 SUBMISSION 0000899243-22-021888 5356
2022-06-10 4 FORM 4 SUBMISSION 0000899243-22-021886 5361
2022-06-09 8-K 8-K 5.07 0001193125-22-171014 001-41199 221005944 34 153635 1 1
2022-06-03 8-K 8-K 8.01,9.01 0001193125-22-166699 001-41199 22992898 34 163237 1 1
2022-05-12 10-Q 10-Q 0000950170-22-009695 001-41199 22918246 34 8353823 1 1
2022-05-12 8-K 8-K 2.02,9.01 0000950170-22-009674 001-41199 22917962 34 350868 1 1
2022-05-06 4 FORM 4 SUBMISSION 0000899243-22-017084 6811
2022-05-06 4 FORM 4 SUBMISSION 0000899243-22-017083 6812
2022-05-05 4 FORM 4 SUBMISSION 0000899243-22-016853 11385
2022-05-05 3 FORM 3 SUBMISSION 0000899243-22-016836 5954
2022-04-29 DEFA14A DEFA14A 0001193125-22-130060 001-41199 22870081 34 779390
2022-04-29 DEF 14A DEF 14A 0001193125-22-130050 001-41199 22870076 34 1126943
2022-03-31 10-K 10-K 0000950170-22-005157 001-41199 22791379 34 5613649
2022-03-31 8-K 8-K 2.02,9.01 0000950170-22-005093 001-41199 22788664 34 196592
2022-03-28 4 FORM 4 SUBMISSION 0000899243-22-012474 5472
2022-03-17 4/A FORM 4/A SUBMISSION 0000899243-22-011432 19691
2022-03-17 3/A FORM 3/A SUBMISSION 0000899243-22-011431 11675
2022-02-28 4 FORM 4 SUBMISSION 0000899243-22-008101 7515
2022-02-28 3 FORM 3 SUBMISSION 0000899243-22-008099 6950
2022-01-25 SC 13D SC 13D 0001193125-22-017123 005-93265 22554587 34 262419
2022-01-25 4 FORM 4 SUBMISSION 0000899243-22-003157 16587
2022-01-25 3 FORM 3 SUBMISSION 0000899243-22-003154 8696
2022-01-21 3 FORM 3 0001567619-22-001444 4971
2022-01-21 SC 13G SC 13G 0001140361-22-002406 005-93265 22546668 34 325341
2022-01-13 4 FORM 4 0001140361-22-001654 21926
2022-01-12 S-8 S-8 0001193125-22-007731 333-262125 22527044 33 347203
2022-01-11 3 FORM 3 0001140361-22-001397 16710
2022-01-11 8-K 8-K 5.03,9.01 0001193125-22-006731 001-41199 22523932 34 150626
2022-01-10 4 FORM 4 SUBMISSION 0000899243-22-001527 6884

Latest XBRL company facts

One latest value per concept from companyfacts (254 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 128.56M 2026-10-26 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
dei EntityPublicFloat Entity Public Float USD 518.20M 2025-06-30 2025 FY 10-K 2026-03-03 0001193125-26-086645
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 5.03M 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001193125-26-171800
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 1.47M 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001193125-26-171800
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 67 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001193125-26-171800
ffd NetFeeAmt NetFeeAmt USD 79,438.47 2026-08-20 424B5 2026-08-20 0001193125-26-359416
ffd NrrtvMaxAggtOfferingPric NrrtvMaxAggtOfferingPric USD 575.22M 2026-08-20 424B5 2026-08-20 0001193125-26-359416
ffd TtlFeeAmt TtlFeeAmt USD 79,438.47 2026-08-20 424B5 2026-08-20 0001193125-26-359416
ffd TtlOfferingAmt TtlOfferingAmt USD 575.22M 2026-08-20 424B5 2026-08-20 0001193125-26-359416
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-08-20 424B5 2026-08-20 0001193125-26-359416
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-08-20 424B5 2026-08-20 0001193125-26-359416
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 4.80M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 88,000 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 2.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 23.31M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 23.31M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 1.55M 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -179,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 1.64B 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 8.32M 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap AdvertisingExpense Advertising Expense USD 2.70M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-04 0000950170-25-031309
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 24.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 16.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap AssetAcquisitionConsiderationTransferred AssetAcquisitionConsiderationTransferred USD 36.20M 2024-07-09 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap AssetAcquisitionConsiderationTransferredTransactionCost AssetAcquisitionConsiderationTransferredTransactionCost USD 1.10M 2024-07-09 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap AssetAcquisitionContingentConsiderationLiability AssetAcquisitionContingentConsiderationLiability USD 0 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 958,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-04 0000950170-25-031309
us-gaap Assets Assets USD 786.79M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap AssetsCurrent Assets, Current USD 778.86M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 240.09M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 241.09M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 241.09M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 13.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 300.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 128.54M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 128.54M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap CommonStockValue Common Stock, Value, Issued USD 13,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -130.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD 0 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018447
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 39.47M 2021-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018447
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap CostsAndExpenses Costs and Expenses USD 139.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 46,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 46,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions Security 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months USD 182.83M 2024-03-31 2024 Q1 10-Q 2024-05-09 0000950170-24-056269
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss USD 52,000 2024-03-31 2024 Q1 10-Q 2024-05-09 0000950170-24-056269
us-gaap DebtSecuritiesAvailableForSaleRealizedGain Debt Securities, Available-for-sale, Realized Gain USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap DebtSecuritiesAvailableForSaleRealizedLoss Debt Securities, Available-for-sale, Realized Loss USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions Security 8 2024-03-31 2024 Q1 10-Q 2024-05-09 0000950170-24-056269
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 0 2022-12-31 2022 FY 10-K 2023-03-13 0000950170-23-007609
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 35,000 2021-12-31 2022 FY 10-K 2023-03-13 0000950170-23-007609
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 7.53M 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 201.02M 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap DeferredTaxAssetsInventory Deferred Tax Assets, Inventory USD 1.09M 2023-12-31 2024 FY 10-K 2025-03-04 0000950170-25-031309
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 1.43M 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 76.04M 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 19.58M 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD -1.43M 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 18.70M 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 4.22M 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other USD 7.40M 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 199.59M 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 1.43M 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 1.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match pure 0.05 2023-10-01 2023 FY 10-K 2024-02-22 0000950170-24-018447
us-gaap Depreciation Depreciation USD 174,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap Dividends Dividends USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap DividendsPayableCurrentAndNoncurrent Dividends Payable USD 0 2023-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018447
us-gaap DividendsPreferredStockCash Dividends, Preferred Stock, Cash USD 0 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-13 0000950170-23-007609
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -1.15 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.93 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0000950170-22-009695
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -1.15 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.196 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure -0.005 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-04 0000950170-25-031309
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.012 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.004 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-04 0000950170-25-031309
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure -0.008 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-04 0000950170-25-031309
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.019 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD -218,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 9.46M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 56.34M 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-11 0000950170-22-016883
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018447
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -144.58M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -144.69M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD -112,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap IncomeTaxesPaid Income Taxes Paid USD 708,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-04 0000950170-25-031309
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD -1.04M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 46,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability USD 500,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0000950170-23-061516
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD -96,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 28.33M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -30.38M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 146,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 1.67M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 37,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 2.73M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 1.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -359,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap IncreaseDecreaseInAccruedInterestReceivableNet Increase (Decrease) in Accrued Interest Receivable, Net USD -24,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 4.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 9.25M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -1.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 2,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-07 0001193125-26-210292
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 4.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 0 2024-12-31 2024 FY 10-K 2025-03-04 0000950170-25-031309
us-gaap InventoryNet Inventory, Net USD 38.32M 2023-12-31 2024 FY 10-K 2025-03-04 0000950170-25-031309
us-gaap InventoryNoncurrent Inventory, Noncurrent USD 44.96M 2023-12-31 2024 FY 10-K 2025-03-04 0000950170-25-031309
us-gaap InventoryRawMaterials Inventory, Raw Materials, Gross USD 0 2024-12-31 2024 FY 10-K 2025-03-04 0000950170-25-031309
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 0 2024-12-31 2024 FY 10-K 2025-03-04 0000950170-25-031309
us-gaap InventoryWriteDown Inventory Write-down USD 92.50M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-04 0000950170-25-031309
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 9.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap LeaseCost Lease, Cost USD 2.17M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-04 0000950170-25-031309
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 7.70M 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 1.85M 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 1.52M 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 1.48M 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 1.44M 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 1.41M 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 611,000 2023-09-30 2023 Q3 10-Q 2023-11-09 0000950170-23-061516
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 1.74M 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap Liabilities Liabilities USD 33.06M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 786.79M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap LiabilitiesCurrent Liabilities, Current USD 29.05M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap LiabilityForClaimsAndClaimsAdjustmentExpense Liability for Claims and Claims Adjustment Expense USD 6.50M 2025-10-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap LossContingencyLossInPeriod Loss Contingency, Loss in Period USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018447
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 528.04M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD 344,000 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0000950170-24-122833
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 554.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -439.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -101.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -130.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 8.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap OperatingExpenses Operating Expenses USD 102.07M 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-11 0000950170-22-016883
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -139.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap OperatingLeaseCost Operating Lease, Cost USD 2.17M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-04 0000950170-25-031309
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 2.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 5.96M 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 932,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 4.01M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap OperatingLeasePayments Operating Lease, Payments USD 1.60M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 4.25M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 2.67M 2021-12-31 2022 FY 10-K 2023-03-13 0000950170-23-007609
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 532,000 2021-12-31 2022 FY 10-K 2023-03-13 0000950170-23-007609
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 476,000 2021-12-31 2022 FY 10-K 2023-03-13 0000950170-23-007609
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 563,000 2021-12-31 2022 FY 10-K 2023-03-13 0000950170-23-007609
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 555,000 2021-12-31 2022 FY 10-K 2023-03-13 0000950170-23-007609
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 541,000 2021-12-31 2022 FY 10-K 2023-03-13 0000950170-23-007609
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 485,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 2.50M 2026-03-31 2026 Q1 10-Q 2026-05-07 0001193125-26-210292
us-gaap OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent USD -386,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, after Tax USD -198,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD -197,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD -583,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -131,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD -75,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -142,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 603.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 36.20M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 200.50M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-06 0001193125-26-336682
us-gaap PaymentsToAcquireProductiveAssets Payments to Acquire Productive Assets USD 35.10M 2024-07-09 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 55,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 10.73M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap ProceedsFromDebtNetOfIssuanceCosts Proceeds from Debt, Net of Issuance Costs USD 544.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap ProceedsFromGrantors Proceeds from Grantors USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-13 0000950170-23-007609
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 200.90M 2022-01-01 2022-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018447
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 2.07M 2021-01-01 2021-06-30 2022 Q2 10-Q 2022-08-11 0000950170-22-016883
us-gaap ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock Proceeds from Issuance of Redeemable Convertible Preferred Stock USD 135.00M 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018447
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 168.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 6.99M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018447
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -130.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 1.86M 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 191,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap PurchaseCommitmentRemainingMinimumAmountCommitted Purchase Commitment, Remaining Minimum Amount Committed USD 0 2023-03-31 2023 Q1 10-Q 2023-05-11 0000950170-23-021369
us-gaap PurchaseObligation Purchase Obligation USD 27.20M 2024-09-30 2024 Q3 10-Q 2024-11-07 0000950170-24-122833
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 79.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost Research and Development Expense (Excluding Acquired in Process Cost) USD 2.70M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018447
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 997,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap RestrictedCashEquivalentsNoncurrent Restricted Cash Equivalents, Noncurrent USD 997,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 1.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap RestructuringCharges Restructuring Charges USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap RestructuringCosts Restructuring Costs USD 22.85M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0000950170-24-122833
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -881.62M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap RevenueNotFromContractWithCustomer Revenue Not from Contract with Customer USD 285,000 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018447
us-gaap Revenues Revenues USD 380.79M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018447
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 5.14M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 230,600 2022-10-01 2022-10-31 2023 FY 10-K 2024-02-22 0000950170-24-018447
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 11.37M 2022-01-01 2022-01-31 2023 FY 10-K 2024-02-22 0000950170-24-018447
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 32 2022-10-31 2023 FY 10-K 2024-02-22 0000950170-24-018447
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 59.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap SettlementLiabilitiesCurrent Settlement Liabilities, Current USD 0 2026-03-31 2026 Q1 10-Q 2026-05-07 0001193125-26-210292
us-gaap SeveranceCosts1 Severance Costs USD 21.80M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 24.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1 Share-based Payment Arrangement, Expensed and Capitalized, Amount USD 400,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018447
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 1.091 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.041 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 83.09M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 5.64M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 14.91 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 16.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 244,654 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 2.97M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 12.14 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 5.25M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price USD/shares 11.16 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 177.94M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 10.89M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 13.1 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 10.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 7.95 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 11.75 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 14.54 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap SharePrice Share Price USD/shares 29.58 2023-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018447
us-gaap ShortTermInvestments Short-term Investments USD 234.81M 2024-06-30 2024 Q2 10-Q 2024-08-08 0000950170-24-093311
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 753.74M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 1.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 239.35M 2022-01-01 2022-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018447
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 544.57M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 5.32M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 239.35M 2021-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018447
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 416.47M 2021-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018447
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 37.71M 2021-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018447
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 37.11M 2021-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018447
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2023-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018447
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD 95,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-22 0000950170-24-018447
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 4.32M 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 725,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary Unrecorded Unconditional Purchase Obligation, to be Paid, Year One USD 18.80M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap UnrecordedUnconditionalPurchaseObligationDueInRemainderOfFiscalYear Unrecorded Unconditional Purchase Obligation, to be Paid, Remainder of Fiscal Year USD 30.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 41.05M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001193125-26-086645
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 2.76M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-04 0000950170-25-031309
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 113.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 51.60M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0000950170-22-009695
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 113.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-448529

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →